About this file

This combined synopsis and solicitation requests quotations for the purchase of 18 units of Promega CellTiter-Glo(R) One Solution Assay 500 ml (Product # G8462) by the National Institutes of Health National Institute on Drug Abuse. Responses are due by February 21, 2024 and must be submitted electronically to the Contracts Specialist. The award will be a firm-fixed price purchase order for delivery within 14 days of order receipt to 9800 Medical Center Drive, Room 315, Rockville, MD 20850-6386. The NAICS code is 325414 and there is no set-aside restriction.

View the file

Other files

File Type Posted
2-FAR 52.225-2.pdf PDF
4-FAR 52.204-24 (Nov 2021).pdf PDF
3-FAR 52.212-4 Addendum.pdf PDF
6-FAR 52.212-5 (Dec 2023).pdf PDF
5-FAR_52.204-26_Oct_2020.pdf PDF
7-Invoicing Instructions With IPP 3-23 (1).pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose: Specific reagent (CellTiter-Glo(R) One Solution Assay 500 ml) needed for Early Translation Branch projects.

2. Background Information and Objective: The National Center for Advancing

Translational Sciences (NCATS) requires the specified reagents for multiple ongoing projects. Promega manufactures a number of reagent systems NCATS uses in multiple ongoing assays and projects. The assay systems and kits allow us to measure specific outcomes of cells. Their products are specifically engineered for high throughput and automation settings, which is the standard at NCATS.

3. Generic Name of Product: Cell viability assay

4. Purchase Description: Promega CellTiter-Glo(R) One Solution Assay 500 ml (Product

# G8462) - BRAND NAME ONLY

5. Salient characteristics:

• CellTiter-Glo one solution is a one-step, homogenous solution used to detect ATP levels that can be used as is without the need for additional reagents.

• Provides a stable, bioluminescent detection method to detect ATP levels and cell viability.

• Can be used and adapted for high-throughput screening methods

• Has a fast acquisition read times of as little as 10 minutes.

6. Quantity: 18

7. Delivery Date: 2 weeks after award

8. Period of Performance: N/A

9. Option(s): N/A

File details come from the government source that posted it. Updated .